MedPath

The effect of melatonin on endometriosis

Phase 3
Conditions
Endometriosis.
Endometriosis
Registration Number
IRCT20171209037794N3
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
98
Inclusion Criteria

Age 18 to 45 years old
Stages 2, 3 and 4 endometriosis (Laparoscopic diagnosis)
Complaint of moderate to severe pelvic pain and dysmenorrhea for more than 3 consecutive months

Exclusion Criteria

Mild pain (number 1-3)
Causes of pelvic pain other than endometriosis
Current malignancy or history of malignancy
Uterine myoma
PID
Ovarian cyst
Pregnancy
Ischemic heart disease
Kidney and liver failure
Regular users of antidepressants and anticonvulsants
Regular users of alcohol and drugs.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dysmenorrgea. Timepoint: Before and after the intervention. Method of measurement: Visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
Size of endometrioma. Timepoint: Before and after intervention. Method of measurement: Sonography.;Number of analgesics. Timepoint: Before and after intervention. Method of measurement: Checklist.;Chronic pelvic pain. Timepoint: Before and after the intervention. Method of measurement: B&B pain scale.
© Copyright 2025. All Rights Reserved by MedPath